Severe Alopecia Areata Patients Without Regrowth of Scalp Hair Benefit from Dose Increase of Baricitinib

This new data may need to be examined by health providers when they advise patients about treatment outcomes for increasing dosage, including those who could benefit from a higher dose of baricitinib.

Related Keywords

United States ,American ,Justinm Ko , ,American Academy Of Dermatology Annual Meeting ,Alopecia Tool ,Stanford University ,Baricitinib Therapy ,Patients With Severe Alopecia Areata ,Pooled Analysis ,Dermatology Annual Meeting ,New Orleans ,